• Mashup Score: 1
    MDS Sessions: iwMDS 2022 - 2 year(s) ago

    Watch our exclusive roundtable discussions from iwMDS 2022 with leading experts in the field, who cover several topics and share their highlights.

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      If you missed out on #iwMDS2022, don't worry! You can catch up with all expert-led roundtable discussions with our latest session🤩 ➡️https://t.co/LiQadCDfXJ⬅️ #MDSsm #MyelodysplasticSyndromes #LeuSM #AMLsm #HemOnc https://t.co/dCKfZHVdbU

  • Mashup Score: 1
    MDS Sessions: iwMDS 2022 - 2 year(s) ago

    Watch our exclusive roundtable discussions from iwMDS 2022 with leading experts in the field, who cover several topics and share their highlights.

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      There were so many interesting discussions at this year's #iwMDS2022 meeting, and we're pleased to bring you our latest session page where you can watch all panel discussions: 🎥: https://t.co/bGmU6EfHi8 #MDSsm #HemOnc #AMLsm #LeuSM @CarrawayHetty @andrewbrunner https://t.co/hj9N5l3cmm

  • Mashup Score: 4
    MDS Sessions: iwMDS 2022 - 2 year(s) ago

    Watch our exclusive roundtable discussions from iwMDS 2022 with leading experts in the field, who cover several topics and share their highlights.

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      📣 Watch our exclusive expert-led discussions from #iwMDS2022 now! Topics include immune dysregulation & targeting, improving the efficiency of drug approvals, updates in classification & more! Watch now: 👉https://t.co/qLN7o9TO4t👈 #MDSsm @Dr_AmerZeidan https://t.co/gChBdmZOxg

  • Mashup Score: 2
    Updates in classification and risk stratification in MDS - 2 year(s) ago

    Classification and risk stratification are crucial for the management and treatment of patients with myelodysplastic syndromes (MDS). For many years,…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      🚨 Want to hear about updates in classification & risk stratification in MDS, including the novel IPSS-M & its future use in disease prognosis? ⬇️Listen to our latest podcast now⬇️! 🎧: https://t.co/XeyQD46lQt #MDSsm #HemOnc #iwMDS2022

  • Mashup Score: 1
    MDS Sessions: iwMDS 2022 - 2 year(s) ago

    Watch our exclusive roundtable discussions from iwMDS 2022 with leading experts in the field, who cover several topics and share their highlights.

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      #iwMDS2022 was filled with several fascinating updates in MDS and we're happy to tell you that our latest session features panel discussions from the meeting.🤩 Find out about updates in classification & risk stratification: 🎥: https://t.co/DOqKgGpaWB #MDSsm @AzizNazhaMD https://t.co/Zny6JucjkF

  • Mashup Score: 3
    MDS Sessions: iwMDS 2022 - 2 year(s) ago

    Watch our exclusive roundtable discussions from iwMDS 2022 with leading experts in the field, who cover several topics and share their highlights.

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      Did you miss #iwMDS2022? Don't worry - we have you covered!🤩 Our latest session page features expert-led discussions from the meeting: ➡️https://t.co/w2zLlRPeHl⬅️ #MDSsm #HemOnc #ImmunoOnc #AMLsm #LeuSM @UwePlatzbecker @dstarczynowski https://t.co/feZMO38DeM